CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.

@article{Maharshak2010CCL2L,
  title={CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.},
  author={Nitsan Maharshak and Gili Hart and Ehud Ron and Einat Zelman and Adi Sagiv and Nadir Arber and Eli Brazowski and Raanan Margalit and Eran Elinav and Idit Shachar},
  journal={Inflammatory bowel diseases},
  year={2010},
  volume={16 9},
  pages={
          1496-504
        }
}
BACKGROUND Chemokines regulate the pathways that restrict homing of specific subsets of immune cells, and thereby fine tune the immune response at specific lymphoid and peripheral tissues. CCL2 is a chemokine that induces migration of monocytes, memory T cells, and dendritic cells. Previously, we demonstrated that pM levels of CCL2 dramatically inhibit migration of T cells. The aim was to test whether subphysiological doses of CCL2 can ameliorate murine colitis and inflammation-induced… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

The effects of vitamin A on cells of innate immunity in vitro.

Toxicology in vitro : an international journal published in association with BIBRA • 2013

Protective effects of Ulmus macrocarpa on experimental colitis mice models

Oriental Pharmacy and Experimental Medicine • 2011
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2008

Similar Papers

Loading similar papers…